Literature DB >> 21254213

In vivo detection of MRI-PARACEST agents in mouse brain tumors at 9.4 T.

Alex X Li1, Mojmir Suchy, Chunhui Li, Joseph S Gati, Susan Meakin, Robert H E Hudson, Ravi S Menon, Robert Bartha.   

Abstract

Paramagnetic chemical exchange saturation transfer (PARACEST) contrast agents are under development for biological target identification by magnetic resonance imaging. Image contrast associated with PARACEST agents can be generated by radiofrequency irradiation of the chemically shifted protons bound to a PARACEST contrast agent molecule or by direct irradiation of the on-resonance bulk water protons. The observed signal change in a magnetic resonance image after the administration of a PARACEST contrast agent is due to both altered relaxation time constants and the CEST effect. Despite high sensitivity in vitro, PARACEST agents have had limited success in vivo where sensitivity is reduced by the magnetization transfer effect from endogenous macromolecules. The purpose of this study was to demonstrate the in vivo detection of a PARACEST contrast agent using the on-resonance paramagnetic chemical exchange effect (OPARACHEE) in a mouse glioblastoma multiforme tumor model and to isolate the OPARACHEE effect from the changes in relaxation induced by the PARACEST agent. Three mice with tumors were imaged on a 9.4 T MRI scanner following tail vein injection of 150 μL 50 mM Tm(3+)-DOTAM-glycine-lysine. A fast low angle shot pulse sequence with a low power radiofrequency pulse train (WALTZ-16) as the preparation pulse was used to generate OPARACHEE contrast. To study the dynamics of agent uptake, reference images (without the preparation pulse) and OPARACHEE images were acquired continuously in an alternating fashion before, during and after agent injection. Signal intensity decreased by more than 10% in tumor in the control images after agent administration. Despite these changes, a clear OPARACHEE contrast of 1-5% was also observed in brain tumors after contrast agent injection and maintained in the hour following injection. This result is the first in vivo observation of OPARACHEE contrast in brain tumors with correction of T(1) and T(2) relaxation effects.
Copyright © 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21254213     DOI: 10.1002/mrm.22772

Source DB:  PubMed          Journal:  Magn Reson Med        ISSN: 0740-3194            Impact factor:   4.668


  14 in total

1.  Improved measurement of labile proton concentration-weighted chemical exchange rate (k(ws)) with experimental factor-compensated and T(1) -normalized quantitative chemical exchange saturation transfer (CEST) MRI.

Authors:  Renhua Wu; Charng-Ming Liu; Philip K Liu; Phillip Zhe Sun
Journal:  Contrast Media Mol Imaging       Date:  2012 Jul-Aug       Impact factor: 3.161

2.  Tumor pH and Protein Concentration Contribute to the Signal of Amide Proton Transfer Magnetic Resonance Imaging.

Authors:  Kevin J Ray; Manon A Simard; James R Larkin; James Coates; Paul Kinchesh; Sean C Smart; Geoff S Higgins; Michael A Chappell; Nicola R Sibson
Journal:  Cancer Res       Date:  2019-01-24       Impact factor: 12.701

3.  QUESPOWR MRI: QUantification of Exchange as a function of Saturation Power On the Water Resonance.

Authors:  Edward A Randtke; Mark D Pagel; Julio Cárdenas-Rodríguez
Journal:  J Magn Reson       Date:  2016-07-01       Impact factor: 2.229

4.  Dichloroacetate induced intracellular acidification in glioblastoma: in vivo detection using AACID-CEST MRI at 9.4 Tesla.

Authors:  Mohammed Albatany; Alex Li; Susan Meakin; Robert Bartha
Journal:  J Neurooncol       Date:  2017-11-16       Impact factor: 4.130

5.  Modulation of CEST images in vivo by T1 relaxation: a new approach in the design of responsive PARACEST agents.

Authors:  S James Ratnakar; Todd C Soesbe; Lloyd Laporca Lumata; Quyen N Do; Subha Viswanathan; Chien-Yuan Lin; A Dean Sherry; Zoltan Kovacs
Journal:  J Am Chem Soc       Date:  2013-09-25       Impact factor: 15.419

6.  CEST: from basic principles to applications, challenges and opportunities.

Authors:  Elena Vinogradov; A Dean Sherry; Robert E Lenkinski
Journal:  J Magn Reson       Date:  2012-12-06       Impact factor: 2.229

7.  A nano-sized PARACEST-fluorescence imaging contrast agent facilitates and validates in vivo CEST MRI detection of glioma.

Authors:  Meser M Ali; Mohammed Pi Bhuiyan; Branislava Janic; Nadimpalli Rs Varma; Tom Mikkelsen; James R Ewing; Robert A Knight; Mark D Pagel; Ali S Arbab
Journal:  Nanomedicine (Lond)       Date:  2012-08-14       Impact factor: 5.307

Review 8.  Chemical exchange saturation transfer magnetic resonance imaging and its main and potential applications in pre-clinical and clinical studies.

Authors:  Weiqiang Dou; Chien-Yuan Eddy Lin; Hongyuan Ding; Yong Shen; Carol Dou; Long Qian; Baohong Wen; Bing Wu
Journal:  Quant Imaging Med Surg       Date:  2019-10

9.  Brain tumor acidification using drugs simultaneously targeting multiple pH regulatory mechanisms.

Authors:  Mohammed Albatany; Valeriy G Ostapchenko; Susan Meakin; Robert Bartha
Journal:  J Neurooncol       Date:  2019-08-07       Impact factor: 4.130

10.  The effect of regioisomerism on the coordination chemistry and CEST properties of lanthanide(III) NB-DOTA-tetraamide chelates.

Authors:  Jacqueline R Slack; Mark Woods
Journal:  J Biol Inorg Chem       Date:  2013-11-28       Impact factor: 3.358

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.